In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Adma Biologics Inc (NASDAQ: ADMA) was $19.45 for the day, down -3.86% from the previous closing price of $20.23. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 2.26 million shares were traded. ADMA stock price reached its highest trading level at $19.78 during the session, while it also had its lowest trading level at $19.2.
Ratios:
Our analysis of ADMA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.84. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when Grossman Adam S sold 21,000 shares for $18.92 per share. The transaction valued at 397,320 led to the insider holds 2,061,850 shares of the business.
Grossman Adam S bought 84,000 shares of ADMA for $1,571,640 on Mar 19 ’25. On Nov 22 ’24, another insider, Tade Brad L., who serves as the CFO and Treasurer of the company, sold 15,000 shares for $21.15 each. As a result, the insider received 317,250 and left with 199,433 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4621612032 and an Enterprise Value of 4600582656. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.03, and their Forward P/E ratio for the next fiscal year is 19.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.84 while its Price-to-Book (P/B) ratio in mrq is 13.19. Its current Enterprise Value per Revenue stands at 10.788 whereas that against EBITDA is 31.291.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.60, which has changed by 2.0438185 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.89. The 50-Day Moving Average of the stock is 11.65%, while the 200-Day Moving Average is calculated to be 14.62%.
Shares Statistics:
ADMA traded an average of 2.75M shares per day over the past three months and 3156030 shares per day over the past ten days. A total of 236.62M shares are outstanding, with a floating share count of 229.29M. Insiders hold about 3.50% of the company’s shares, while institutions hold 86.21% stake in the company. Shares short for ADMA as of 1741910400 were 15069973 with a Short Ratio of 5.47, compared to 1739491200 on 13739629. Therefore, it implies a Short% of Shares Outstanding of 15069973 and a Short% of Float of 6.529999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
